In a mixed interim data drop,…
In a mixed interim data drop, Arcturus Therapeutics has revealed [...]
In a mixed interim data drop, Arcturus Therapeutics has revealed [...]
Alector Therapeutics is shelving a GSK-partnered antibody after the asset [...]
There is no F.D.A.-approved testosterone product for women. Insurance won’t [...]
With $70 million and a phase 2 ready asset in [...]
Axial Therapeutics has stepped back into the spotlight, emerging after [...]
“We need to pick a lane here as a country. [...]
Novo said Tuesday that it will host an extraordinary general [...]
GSK and Spero Therapeutics have shared phase 3 results on [...]
After rejecting Replimune’s melanoma drug RP1 this summer, the FDA [...]
The U.S. private equity market is showing signs of recovery, [...]